ASX - By Stock
|
VRX |
Re:
Ann: Mineral Assay Results for Muchea High Grade Silica Flour
|
|
trinity168
|
24 |
4.5K |
5 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
24
|
4.5K
|
5
|
|
ASX - By Stock
|
VRX |
Re:
Ann: Mineral Assay Results for Muchea High Grade Silica Flour
|
|
trinity168
|
24 |
4.5K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
24
|
4.5K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
trinity168
|
126 |
27K |
8 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
126
|
27K
|
8
|
|
ASX - By Stock
|
VRX |
Re:
Ann: Letter to Ineligible Shareholders
|
|
trinity168
|
2 |
772 |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
2
|
772
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Annoying adverts
|
|
trinity168
|
25 |
5.7K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
25
|
5.7K
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
trinity168
|
10K |
3.7M |
19 |
07/03/24 |
07/03/24 |
General
|
10K
|
3.7M
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology 2023 Chair's Address & AGM Presentation
|
|
trinity168
|
75 |
20K |
9 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
75
|
20K
|
9
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
trinity168
|
10K |
3.7M |
4 |
25/11/23 |
25/11/23 |
General
|
10K
|
3.7M
|
4
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
trinity168
|
2.0K |
669K |
14 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
2.0K
|
669K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
trinity168
|
2.0K |
669K |
1 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
2.0K
|
669K
|
1
|
|
ASX - By Stock
|
TIE |
Re:
Ann: Response to Zhaojin Takeover Offer
|
|
trinity168
|
112 |
35K |
5 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
112
|
35K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Final Director's Interest Notice-Damian Clarke-Bruce
|
|
trinity168
|
42 |
13K |
10 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
42
|
13K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
trinity168
|
450 |
145K |
4 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
450
|
145K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Final Director's Interest Notice-Damian Clarke-Bruce
|
|
trinity168
|
42 |
13K |
2 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
42
|
13K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Final Director's Interest Notice-Damian Clarke-Bruce
|
|
trinity168
|
42 |
13K |
1 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
42
|
13K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
trinity168
|
450 |
145K |
5 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
450
|
145K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
trinity168
|
450 |
145K |
4 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
450
|
145K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
trinity168
|
450 |
145K |
37 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
450
|
145K
|
37
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
trinity168
|
450 |
145K |
47 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
450
|
145K
|
47
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases cardioprotection market potential data
|
|
trinity168
|
239 |
95K |
10 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
239
|
95K
|
10
|
|
ASX - By Stock
|
ARG |
Re:
Ann: Key Dates
|
|
trinity168
|
1 |
1.3K |
0 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
1
|
1.3K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Develops Improved IV Formulation of Zantrene
|
|
trinity168
|
90 |
35K |
32 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
90
|
35K
|
32
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Focus on increasing confidence in Cu-Co MREs
|
|
trinity168
|
4 |
2.6K |
2 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
4
|
2.6K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage
|
|
trinity168
|
112 |
39K |
5 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
112
|
39K
|
5
|
|
ASX - By Stock
|
TIE |
Re:
Ann: Step-Out Drilling Extends Gold Mineralisation by 4,600m
|
|
trinity168
|
18 |
7.0K |
5 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
18
|
7.0K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene shows synergy with kinase inhibitors in melanoma
|
|
trinity168
|
45 |
20K |
16 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
45
|
20K
|
16
|
|
ASX - By Stock
|
TIE |
Re:
Ann: Tietto Hits 1.40m @ 262.59g/t Au from 32m at AG Core
|
|
trinity168
|
18 |
7.1K |
5 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
18
|
7.1K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race raises $29.7 million in oversubscribed SPP
|
|
trinity168
|
378 |
99K |
10 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
378
|
99K
|
10
|
|
ASX - By Stock
|
TIE |
Re:
Ann: Fully Funded Abujar Gold Project Development Gains Momentum
|
|
trinity168
|
22 |
7.0K |
9 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
22
|
7.0K
|
9
|
|
ASX - By Stock
|
GNM |
Re:
Ann: Trading Halt
|
|
trinity168
|
19 |
5.0K |
5 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
19
|
5.0K
|
5
|
|
ASX - By Stock
|
GNM |
GNM in the media
|
|
trinity168
|
1 |
479 |
6 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
1
|
479
|
6
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
trinity168
|
2.0K |
669K |
21 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
2.0K
|
669K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race online Q&A investor briefing invitation
|
|
trinity168
|
126 |
37K |
29 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
126
|
37K
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race online Q&A investor briefing invitation
|
|
trinity168
|
126 |
37K |
24 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
126
|
37K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race online Q&A investor briefing invitation
|
|
trinity168
|
126 |
37K |
36 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
126
|
37K
|
36
|
|
ASX - By Stock
|
GNM |
Re:
Have they started drilling?
|
|
trinity168
|
3 |
1.0K |
3 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
3
|
1.0K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Breakthrough Zantrene Heart Protection Discovery
|
|
trinity168
|
366 |
119K |
20 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
366
|
119K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Breakthrough Zantrene Heart Protection Discovery
|
|
trinity168
|
366 |
119K |
48 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
366
|
119K
|
48
|
|
ASX - By Stock
|
TIE |
Re:
Ann: Tietto Hits 8m @12.43g/t Au incl. 2m @48.37g/t at AG Core
|
|
trinity168
|
9 |
3.3K |
5 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
9
|
3.3K
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
trinity168
|
20K |
6.9M |
2 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
20K
|
6.9M
|
2
|
|
ASX - By Stock
|
BDC |
Re:
Ann: Bardoc Management Update
|
|
trinity168
|
52 |
16K |
4 |
04/10/21 |
04/10/21 |
ASX - By Stock
|
52
|
16K
|
4
|
|
ASX - By Stock
|
BDC |
Re:
Ann: Change of Director's Interest Notice
|
|
trinity168
|
6 |
2.5K |
6 |
04/10/21 |
04/10/21 |
ASX - By Stock
|
6
|
2.5K
|
6
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
trinity168
|
10K |
3.7M |
30 |
27/09/21 |
27/09/21 |
General
|
10K
|
3.7M
|
30
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Change of Director's Interest Notice - Scott & Paull
|
|
trinity168
|
3 |
2.3K |
2 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
3
|
2.3K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
trinity168
|
2.0K |
669K |
16 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
2.0K
|
669K
|
16
|
|
ASX - By Stock
|
WTM |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
trinity168
|
6 |
3.7K |
13 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
6
|
3.7K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
trinity168
|
701 |
256K |
2 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
701
|
256K
|
2
|
|
ASX - By Stock
|
NVX |
Re:
Ann: Letter to Shareholders
|
|
trinity168
|
5 |
3.7K |
4 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
5
|
3.7K
|
4
|
|
ASX - By Stock
|
NVX |
Re:
Ann: Letter to Shareholders
|
|
trinity168
|
5 |
3.7K |
2 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
5
|
3.7K
|
2
|
|
ASX - By Stock
|
NVX |
Re:
Ann: Update of Employment Terms for CEO and CFO
|
|
trinity168
|
76 |
28K |
0 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
76
|
28K
|
0
|
|